Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) is a publicly traded Healthcare sector company. As of September 18, 2026, ARCT trades at $16.92 with a market cap of $443.40M and a P/E ratio of -5.25. ARCT moved +1.09% today. Year to date, ARCT is +170.88%; over the trailing twelve months it is -6.20%. Its 52-week range spans $5.50 to $24.17. Analyst consensus is moderatebuy with an average price target of $21.33. Rallies surfaces ARCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ARCT moved +1.09% today. Analyst consensus is moderatebuy.
| Metric | Value |
|---|---|
| Price | $16.92 |
| Market Cap | $443.40M |
| P/E Ratio | -5.25 |
| EPS | $-3.33 |
| Dividend Yield | 0.00% |
| 52-Week High | $24.17 |
| 52-Week Low | $5.50 |
| Volume | 162.75K |
| Avg Volume | 0 |
| Revenue (TTM) | $29.37M |
| Net Income | $-93.28M |
| Gross Margin | 0.00% |
8 analysts cover ARCT: 0 strong buy, 5 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is moderatebuy. Average price target: $21.33.